AEMDAETHLON MEDICAL INC

Nasdaq aethlonmedical.com


$ 0.44 $ 0.00 (-0.02 %)    

Thursday, 16-May-2024 11:41:58 EDT
QQQ $ 453.86 $ 0.39 (0.09 %)
DIA $ 400.37 $ 0.73 (0.18 %)
SPY $ 530.58 $ 0.60 (0.11 %)
TLT $ 92.12 $ -0.28 (-0.3 %)
GLD $ 220.30 $ 0.29 (0.13 %)
$ 0.4
$ 0.44
$ 0.45 x 200
$ 0.00 x 0
$ 0.44 - $ 0.47
$ 0.37 - $ 5.00
7,733,706
na
1.05M
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-14-2024 12-31-2023 10-Q
2 11-14-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 06-28-2023 03-31-2023 10-K
5 02-13-2023 12-31-2022 10-Q
6 11-14-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 06-28-2022 03-31-2022 10-K
9 02-14-2022 12-31-2021 10-Q
10 11-09-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 06-24-2021 03-31-2021 10-K
13 02-10-2021 12-31-2020 10-Q
14 10-28-2020 09-30-2020 10-Q
15 08-11-2020 06-30-2020 10-Q
16 06-25-2020 03-31-2020 10-K
17 02-10-2020 12-31-2019 10-Q
18 11-01-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 07-01-2019 03-31-2019 10-K
21 02-11-2019 12-31-2018 10-Q
22 11-06-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 06-08-2018 03-31-2018 10-K
25 02-01-2018 12-31-2017 10-Q
26 11-02-2017 09-30-2017 10-Q
27 08-10-2017 06-30-2017 10-Q
28 06-28-2017 03-31-2017 10-K
29 02-10-2017 12-31-2016 10-Q
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 06-29-2016 03-31-2016 10-K
33 02-04-2016 12-31-2015 10-Q
34 11-16-2015 09-30-2015 10-Q
35 08-13-2015 06-30-2015 10-Q
36 06-26-2015 03-31-2015 10-K
37 02-10-2015 12-31-2014 10-Q
38 11-10-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 07-15-2014 03-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-medical-therapeutic-firm-aethlon-medical-on-friday

Aethlon Medical unveils results in removing extracellular vesicles (EVs) from plasma. Preclinical evidence supports upcoming ph...

Core News & Articles

https://twitter.com/DrTedros/status/1778423967105139108  

 hc-wainwright--co-maintains-buy-on-aethlon-medical-lowers-price-target-to-10

HC Wainwright & Co. analyst Vernon Bernardino maintains Aethlon Medical (NASDAQ:AEMD) with a Buy and lowers the price ta...

 aethlon-medical-enters-into-materials-transfer-agreement-for-santersus-ags-nucleocapture-and-hemonucleocapture-devices

Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier® Blood Fi...

 aethlon-medical-q3-eps-137-misses-123-estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(1...

 earnings-scheduled-for-february-14-2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION